Scientists hunt for narcolepsy clues in body fluids

NCT ID NCT06279247

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at proteins and metabolites in the body fluids of 60 people with narcolepsy, a rare sleep disorder. The goal is to find biological markers that could explain what causes the condition and help doctors diagnose it more accurately. Participants provide samples for analysis, and no treatment is being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could identify biological markers that help doctors diagnose narcolepsy more accurately and understand its underlying causes.

What could go wrong

This is an early observational study with only 60 participants, so findings may not apply to everyone with narcolepsy. It is designed to gather knowledge, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NARCOLEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

narcolepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Qilu Hospital of Shandong University

    RECRUITING

    Jinan, Shandong, 250012, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••